Diazinanes (total related compounds in database) |
|
|
4-methyl-2-(4-methylphenyl)-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
4-methyl-2-phenyl-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
Depiction based on curated SMILES
N
N
N
O
N
O
N
O
CH
3
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
6-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-(pyridin-4-yl)pyridazin-3-amine |
Depiction based on curated SMILES
N
N
N
N
H
CH
3
N
N
O
O
S
CH
3
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
3,5-di(3-pyridylmethyl)-1,3,5-thiadiazinane-2-thione |
Depiction based on curated SMILES
N
N
S
S
N
N
|
Shigella |
VirF |
Preclinical (in vitro) |
Hurt JK, et al. 2010. J Biomol Screen |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.
|
Back to top |
|